Evaluation of miRNAs 9 and 342 expressions in sera as diagnostic and prognostic biomarkers for breast cancer.

Breast Dis

Department of Pharmacology and Biochemistry, Faculty of Pharmaceutical Sciences & Pharmaceutical Industries, Future University in Egypt, Cairo, Egypt.

Published: January 2022

Objective: Molecular markers for the detection of breast cancer and its different types, grades, and stages lack enough sensitivity and specificity. This study evaluates the expression of miRNAs 9 and 342 in sera of different types, grades, and stages of BC. Moreover, the assessment of their sensitivity, specificity, diagnostic, and prognostic role in detecting different types of BC.

Methods: Blood was collected from 200 females outpatients, divided into five groups each 40 subjects: control, benign breast tumor, estrogen receptor (ER+)/progesterone receptor (PR+) BC, human epidermal growth factor receptor (HER+) BC, and triple-negative BC. BC subjects were further subdivided according to grade and stage. Expressions of miRNAs 9 and 342 were measured for all subjects by real-time polymerase chain reaction (RT-PCR).

Results: Results showed that serum expression of both miRNAs 9 and 342 can be used for the diagnosis of different types of BC. Their expression can be used to significantly differentiate between different grades and stages of BC. MiRNAs 9 and 342 showed high sensitivity of 92.5% and specificity of (81.2 and 88.7%), respectively, for triple-negative BC.

Conclusion: The expressions of miRNAs 9 and 342 provide potential roles as serological biomarkers for the diagnosis and prognosis of different types, grades, and stages of BC.

Download full-text PDF

Source
http://dx.doi.org/10.3233/BD-201076DOI Listing

Publication Analysis

Top Keywords

mirnas 342
24
grades stages
16
types grades
12
diagnostic prognostic
8
breast cancer
8
sensitivity specificity
8
expression mirnas
8
expressions mirnas
8
0
6
types
5

Similar Publications

Abnormal microRNA expression profile at early stages of gestation in pregnancies destined to develop placenta previa.

Front Med (Lausanne)

December 2024

Institute for the Care of the Mother and Child, Third Faculty of Medicine, Charles University, Prague, Czechia.

Article Synopsis
  • Placenta previa is a condition where the placenta implants abnormally in the lower uterus, leading to serious risks for both the mother and fetus, including hemorrhage and stillbirth.
  • This study focused on analyzing microRNA expression in the blood during the first trimester of pregnancies that later developed placenta previa, comparing them to normal pregnancies.
  • The results showed that several microRNAs were downregulated in those pregnancies, with a combination of seven specific microRNAs accurately distinguishing between healthy and placenta previa pregnancies early on.
View Article and Find Full Text PDF

Objective: To corroborate the efficacy of Jintiange capsules (JTGs) in the treatment of osteoarthritis (OA) by exploring the potential mechanism of action of synovial mesenchymal stem cell exosomes (SMSC-Exos) and articular chondrocytes (ACs) through transcriptome sequencing (RNA-seq).

Methods: Type II collagenase was used to induce OA in rats. The efficacy of JTGs was confirmed by macroscopic observation of articular cartilage, micro-CT observation, and safranin fast green staining.

View Article and Find Full Text PDF

Blood Screening of Femtomole Level Multiple Alzheimer's Disease Biomarkers by Metal Isotopic DNA Walkers.

Anal Chem

December 2024

Key Laboratory of Green Chemistry & Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, China.

Aging is a critical global issue that contributes to the high incidence of Alzheimer's disease (AD). Blood screening emerges as the most promising measure for early diagnosis and intervention of AD due to its noninvasive and low cost. However, the practical application of AD blood screening confronts two significant challenges.

View Article and Find Full Text PDF

Extracellular vesicles (EVs) are double-membrane vesicles that facilitate intercellular communication and play a pivotal role in both physiological and pathological processes. A substantial body of evidence suggests that EVs play a role in the pathogenesis of various pregnancy complications. Because EVs can be detected in the peripheral blood, they are potential biomarkers for the early diagnosis of pregnancy complications and foetal developmental disorders.

View Article and Find Full Text PDF

Macrophage-derived extracellular vesicles from antigen exposure enhance growth control, reduce IL-1β, and contain miR-342-5p, miR-516b-5p, and miR-570-3p that regulate PI3K/AKT and MAPK signaling pathways.

Front Immunol

November 2024

Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden.

Background: Helminth coinfection with tuberculosis (TB) can alter the phenotype and function of macrophages, which are the major host cells responsible for controlling (Mtb). However, it is not known whether helminth infection stimulates the release of host-derived extracellular vesicles (EVs) to induce or maintain their regulatory network that suppresses TB immunity. We previously showed that pre-exposure of human monocyte-derived macrophages (hMDMs) with protein antigens (ASC) results in reduced Mtb infection-driven proinflammation and gained bacterial control.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!